231 related articles for article (PubMed ID: 3056862)
1. Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan.
Akizawa T; Koshikawa S; Takaku F; Urabe A; Akiyama N; Mimura N; Otsubo O; Nihei H; Suzuki Y; Kawaguchi Y
Int J Artif Organs; 1988 Sep; 11(5):343-50. PubMed ID: 3056862
[TBL] [Abstract][Full Text] [Related]
2. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of anemia in patients with renal failure using erythropoietin obtained by genetic recombination].
Wiecek A; Kokot F; Grzeszczak W; Klin M
Pol Tyg Lek; 1990 Sep 17-24; 45(38-39):782-6. PubMed ID: 2095546
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
Mohini R
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
[TBL] [Abstract][Full Text] [Related]
5. Who should receive recombinant human erythropoietin?
Van Stone JC
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):3-7. PubMed ID: 2669084
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group.
Kulzer P; Schaefer RM; Krahn R; Schaefer L; Heidland A
Int J Artif Organs; 1994 Apr; 17(4):195-202. PubMed ID: 8070941
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
8. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients.
Abraham PA; Opsahl JA; Rachael KM; Asinger R; Halstenson CE
Am J Nephrol; 1990; 10(2):128-36. PubMed ID: 2349956
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
[TBL] [Abstract][Full Text] [Related]
10. Blood rheology and hypertension in hemodialysis patients treated with erythropoietin.
Schaefer RM; Leschke M; Strauer BE; Heidland A
Am J Nephrol; 1988; 8(6):449-53. PubMed ID: 3218658
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
[TBL] [Abstract][Full Text] [Related]
12. Monitoring considerations in recombinant human erythropoietin therapy.
Ogden DA
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
[TBL] [Abstract][Full Text] [Related]
13. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F
Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875
[TBL] [Abstract][Full Text] [Related]
14. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
Zehnder C; Blumberg A
Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
[TBL] [Abstract][Full Text] [Related]
15. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
[TBL] [Abstract][Full Text] [Related]
16. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin].
Sivak L; Scuteri RM; Cavalli NH; Gotlieb D; López Blanco OA
Medicina (B Aires); 1992; 52(6):516-22. PubMed ID: 1340900
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.
Roth D; Smith RD; Schulman G; Steinman TI; Hatch FE; Rudnick MR; Sloand JA; Freedman BI; Williams WW; Shadur CA
Am J Kidney Dis; 1994 Nov; 24(5):777-84. PubMed ID: 7977319
[TBL] [Abstract][Full Text] [Related]
18. Low-dose recombinant human erythropoietin therapy in chronic hemodialysis patients.
Duff DR; Golper TA; Sloan RS; Brier ME; Aronoff GR
Am J Kidney Dis; 1991 Jul; 18(1):60-4. PubMed ID: 2063856
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure.
Aucella F; Vigilante M; Scalzulli P; Musto P; Prencipe M; Valente GL; Carotenuto M; Stallone C
Nephrol Dial Transplant; 1999 May; 14(5):1171-5. PubMed ID: 10344357
[TBL] [Abstract][Full Text] [Related]
20. Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial.
Stone WJ; Graber SE; Krantz SB; Dessypris EN; O'Neil VL; Olsen NJ; Pincus TP
Am J Med Sci; 1988 Sep; 296(3):171-9. PubMed ID: 3177433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]